Viewing Study NCT02842359


Ignite Creation Date: 2025-12-24 @ 2:38 PM
Ignite Modification Date: 2026-02-01 @ 12:18 PM
Study NCT ID: NCT02842359
Status: COMPLETED
Last Update Posted: 2022-04-13
First Post: 2016-07-20
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Evaluation of the Fixed-dose Combination of Irbesartan/Atorvastatin in Type 2 Diabetic Patients Diagnosed With Hyperlipidemia and Hypertension
Sponsor: Sanofi
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2016-08-23
Start Date Type: ACTUAL
Primary Completion Date: 2018-04-19
Primary Completion Date Type: ACTUAL
Completion Date: 2018-04-19
Completion Date Type: ACTUAL
First Submit Date: 2016-07-20
First Submit QC Date: None
Study First Post Date: 2016-07-22
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2022-04-05
Last Update Post Date: 2022-04-13
Last Update Post Date Type: ACTUAL